About Us

Who We Are

Exonox Biosciences, Inc. focus on clinical and disease-oriented biomarkers from liquid biopsy such as blood, serum/plasma, urine.  The biomarkers include but not limited to proteins, small-molecule metabolites and exosomes.

There is more consensus that precision medicine and therapy cannot live without early detection, diagnosis or intervention at the early or super-early of disease progression. With the development of high specificity and sensitivity diagnostic tools will largely help physicians to treat patients in an optimal way.

Our Platform Discovery Strategy

  • Un-supervising screening strategy: top-down approach to avoid missing important biomarkers than just done with hand-pick ones.
  • Cutting edge technology: high definition and quantitively-centered tools are applied to the discovery platform.
analysis

Our Strength

  • Novel disease biomarker development experiences
  • Expert in “Targeted and Untargeted Mass Spectrometry-Based Proteomics”
  • Many years of experiences in human clinical trial design
  • Good at intellectual property strategy and protection
  • Demand-oriented approach and business development
  • IVD co-development partners with successful track record

Key Management Team

man_circle

Wei-Min Wang, Ph.D.

Co-Founder &
Chief Executive Officer

  • Senior Executive Assistant to CEO, Senhwa Biosciences Ltd. (TW: 6492)
  • Biotech Consultant, Black Marble Asset Management
  • President, IBTS Investment Consultant
  • Vice President, Research Department Polaris Securities Co. Ltd.
ted

Wei-Cheng Su, D.V.M

COO &
Clinical Regulatory Affair

  • Senior Staff Scientist, Cardiovascular & Renal Division, Regeneron Pharma., Inc (NASDAQ: REGN)
  • Director, Taiwan Liposome Comp., Inc. (TW: 4152)
  • Postdoctoral Fellow in Medicine, NIH T32 clinical fellow in Translational Medicine, New York University Medical Center
  • Drug in market: EYLEA, Praluent
cyn

Hsing-Chuan Hsieh

Director,
Intellectual Property

  • Licensing Associate, Office of Public affairs, Academia Sinica
  • IP Management Manager, Center of Industry - Academia Collaboration, Office of Research and Development, National Taiwan University
  • Director of Incubation Center, NHRI
iris2

Hung-Yun Lin

Project Manager,
Clinical Trial

  • Medical Specialist, BalDr Strategic Consulting (Hong Kong) Ltd. Taiwan Branch
  • Research Assistant, Department of Agricultural Chemistry, National Taiwan University
yuting

Yu-Ting Huang

Research Scientist,
Research & Development

  • Research Assistant, Proteomics Core Laboratory, Department of Medical Research, China Medical University Hospital, Taichung , Taiwan
  • Research Assistant, Department of Medical Research , Stem Cell Research Lab., China Medical University Hospital , Taichung , Taiwan

Board of Directors